Cargando…
Validation of suitable normalizers for miR expression patterns analysis covering tumour heterogeneity
Oncogenic microRNAs (miRs) have emerged as diagnostic biomarkers and novel molecular targets for anti-cancer drug therapies. Real-time quantitative PCR (qPCR) is one of the most powerful techniques for analyzing miRs; however, the use of unsuitable normalizers might bias the results. Tumour heteroge...
Autores principales: | Morata-Tarifa, C., Picon-Ruiz, M., Griñan-Lison, C., Boulaiz, H., Perán, M., Garcia, M. A., Marchal, J. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5209713/ https://www.ncbi.nlm.nih.gov/pubmed/28051134 http://dx.doi.org/10.1038/srep39782 |
Ejemplares similares
-
Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells
por: Morata-Tarifa, Cynthia, et al.
Publicado: (2016) -
miRNAs as radio‐response biomarkers for breast cancer stem cells
por: Griñán‐Lisón, Carmen, et al.
Publicado: (2020) -
HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib
por: Ramírez, Alberto, et al.
Publicado: (2014) -
Pancreatic (pro)enzymes treatment suppresses BXPC-3 pancreatic Cancer Stem Cell subpopulation and impairs tumour engrafting
por: Hernández-Camarero, Pablo, et al.
Publicado: (2019) -
Dual Role of Fibroblasts Educated by Tumour in Cancer Behavior and Therapeutic Perspectives
por: Toledo, Belén, et al.
Publicado: (2022)